ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Clovis Oncology Inc

Clovis Oncology Inc (CLVS)

0.0812
0.00
(0.00%)
Closed August 24 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0812
Bid
0.0792
Ask
0.0811
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.0812
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CLVS Latest News

Clovis Oncology Shares Fall Premarket After Bankruptcy Filing

By Colin Kellaher Shares of Clovis Oncology Inc. slid nearly 10% in premarket trading Monday after the biopharmaceutical company said it filed for chapter 11 bankruptcy with plans to auction off...

Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286

Receives Commitment for up to $75 Million in Debtor-in-Possession Financing Clovis Oncology, Inc. (NASDAQ:CLVS) (“Clovis” or the Company”), a biopharmaceutical company focused on acquiring...

Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the presentation of data from the TRITON3 Phase 3 trial in men with metastatic castration-resistant prostate cancer with BRCA or ATM...

Clovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM Congress

Updated LuMIERE Phase 1 data demonstrated a manageable safety profile with some preliminary evidence of anti-tumor activity Eleven patients treated to date with 177Lu-FAP-2286 up to 7.4 GBq/dose...

TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations

TRITON3 study evaluating Rubraca monotherapy versus chemotherapy or second-line androgen deprivation therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) with...

Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement

Isotopia to supply its medical radioisotope, lutetium-177, for the clinical development of Clovis Oncology’s targeted radionuclide therapy candidate FAP-2286 Clovis Oncology, Inc. (NASDAQ: CLVS...

Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer

Submissions based on data from the Phase 3 ATHENA trial evaluating Rubraca monotherapy versus placebo (ATHENA-MONO) presented at ASCO 2022 The ATHENA-MONO trial met its primary endpoint, showing...

Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups

Subgroup analysis from the Phase 3 ATHENA trial evaluating Rubraca monotherapy versus placebo (ATHENA-MONO) presented in a Mini Oral session at the ESMO Congress 2022 Results reinforce potential...

Clovis Oncology Announces Second Quarter 2022 Operating Results and Provides Update on Clinical Development Programs

First presentation of initial LuMIERE Phase 1 clinical data for FAP-2286 targeted radiotherapy candidate at SNMMI demonstrated a manageable safety profile with preliminary evidence of activity...

CORRECTING and REPLACING Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8

First paragraph, second sentence of release should read: Clovis’ senior management will host a conference call and live audio webcast at 8:30am ET to discuss Clovis’ results and business outlook...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRTGPortage Biotech Inc
$ 5.90
(118.49%)
49.67M
MNTSMomentus Inc
$ 1.04
(80.65%)
231.74M
GHSIGuardion Health Sciences Inc
$ 17.91
(58.50%)
561.42k
RETOReTo Eco Solutions Inc
$ 1.591
(52.98%)
3.45M
HUBCWHub Cyber Security Ltd
$ 0.0149
(40.57%)
40.79k
UBXGU BX Technology Ltd
$ 2.38
(-92.54%)
35.79M
FAMIFarmmi Inc
$ 0.2336
(-58.76%)
14.1M
GDCGD Culture Group Ltd
$ 5.43
(-29.94%)
28.75M
NUWENewellis Inc
$ 1.26
(-26.74%)
754.69k
TGLTreasure Global Inc
$ 0.85
(-25.44%)
1.4M
NVDANVIDIA Corporation
$ 129.37
(4.55%)
323.15M
MNTSMomentus Inc
$ 1.04
(80.65%)
231.74M
SQQQProShares UltraPro Short QQQ
$ 7.98
(-3.16%)
186.3M
MULNMullen Automotive Inc
$ 0.3321
(-7.62%)
140.97M
APDNApplied DNA Sciences Inc
$ 2.4901
(36.07%)
127.34M

Discussion

View Full Feed
Jack_Bolander Jack_Bolander 2 minutes ago
Who cares to manipulate a 6 cent stock ?

It looks like HYZN is quickly running out of options and time .
HYZN
glenn1919 glenn1919 3 minutes ago
LOOP................................https://stockcharts.com/h-sc/ui?s=LOOP&p=W&b=5&g=0&id=p86431144783
LOOP
show_me_money show_me_money 3 minutes ago
All in. $$$
XRPUSD
DiscoverGold DiscoverGold 3 minutes ago
Gold Market Update - MASSIVE PARABOLIC SLINGSHOT MOVE STARTING......
By: Clive Maund | August 19, 2024

Because gold has not done all that much since its April – May peaks many investors are unaware of the magnitude of the upleg that has begun so the purpose of this update
GLD
NeutrinoKid NeutrinoKid 4 minutes ago
So the nature of the uncertainty is about whether going to the EM was intentional. If it really is not so, then what happening is hard to make sense of. If it is then something huge is brewing, and they, or some third parties sought to minimize interference. A sandbox.
RSPI
flipper44 flipper44 4 minutes ago
learningcurve2020:
Yesterday
”I have serious doubts based on the lack of side effects.”

December 2023
“I believe there is something to DCVAX's MOA and perhaps showing some good signals from the Plll.”

October 2023
”I've always said the scien
NWBO
glenn1919 glenn1919 5 minutes ago
PRCH...........................https://stockcharts.com/h-sc/ui?s=PRCH&p=W&b=5&g=0&id=p86431144783
PRCH
DiscoverGold DiscoverGold 5 minutes ago
NY Crude Oil Futures »» Weekly Summary Analysis
By: Marty Armstrong | August 24, 2024

The NY Crude Oil Futures has been in an uptrend for the past 2 days closing above the previous session's high quite significantly by 1.78%. Currently, the market is trading in a neutral p
OILBRENT
Lonewolf6 Lonewolf6 5 minutes ago
PureZoob, he may have sold shares in another company in order to fund his cash infusion, but I am sure he did not sell any LBRMF shares.
If he had, he would have been required to disclose this in a filing.
As well, at a price of $.05 per share, the approximate price during the time he
LBRMF
drugrunner drugrunner 6 minutes ago
You clocked in really early even for you today your masters must be getting nervous
NWBO
glenn1919 glenn1919 6 minutes ago
BHAT........................https://stockcharts.com/h-sc/ui?s=BHAT&p=W&b=5&g=0&id=p86431144783
BHAT
Catmandoo Catmandoo 6 minutes ago
OMG, two clowns still here all day all night wasting their life away for a subpenny stock, geez somebody must be awfully worried and paying for a bunch of repeated nonsense that has absolutely no bearing on Nsav. Geez I don't like a stock but I will devote my every waking hour to tell you how bad it
NSAV
DiscoverGold DiscoverGold 6 minutes ago
NY Silver COMEX Futures »» Weekly Summary Analysis
By: Marty Armstrong | August 24, 2024

NY Silver COMEX Futures closed today at 29820 and is trading up about 23% for the year from last year's settlement of 24086. Caution is required for this market is starting to suggest
SILVER
TOM611 TOM611 6 minutes ago
Go. XALL. Great week.
XALL
jman4956 jman4956 7 minutes ago
I don’t see this taking 10+ years. The Main reason this is taking so long is because none of the regulators had any guidance in place for a personalized living cell therapy. I believe when we get MHRA approval they will be ready and D will move through the exact same process the exact same way much
NWBO
glenn1919 glenn1919 7 minutes ago
ELAB...................................................https://stockcharts.com/h-sc/ui?s=ELAB&p=W&b=5&g=0&id=p86431144783
ELAB
drugrunner drugrunner 7 minutes ago
Hey LC, how many different alias profiles are you gonna be running today. And what are the bash you’re talking points? I’m trying to catch up.
NWBO
DiscoverGold DiscoverGold 8 minutes ago
NY Gold Futures »» Weekly Summary Analysis
By: Marty Armstrong | August 24, 2024

NY Gold Futures closed today at 25463 and is trading up about 22% for the year from last year's settlement of 20718. Presently, this market has been rising for 9 months going into August sugge
GLD
HD2001 HD2001 8 minutes ago
If zhud comes in next week I'll have the money to file my lawsuit against xalles . The court has discharged the receivership of $ZHUD. We plan to share more news in the coming week regarding the company’s future.
ZHUD
DiscoverGold DiscoverGold 8 minutes ago
NY Gold Futures »» Weekly Summary Analysis
By: Marty Armstrong | August 24, 2024

NY Gold Futures closed today at 25463 and is trading up about 22% for the year from last year's settlement of 20718. Presently, this market has been rising for 9 months going into August sugge
GOLD
12yearplan 12yearplan 8 minutes ago
Sorta, why are you calling recycling receptacles trash receptacles ?
Why not find some trash receptacles ?
Gmenfan Gmenfan 9 minutes ago
Why are nonprofit groups setting up voter registration booths outside of driver’s license offices in Texas?

By Olivia Murray

Every time I’ve ever applied for a new driver’s license while also being involved in the voting process (Arizona, Tennessee, and now Alabama), I’
Gmenfan Gmenfan 9 minutes ago
Why are nonprofit groups setting up voter registration booths outside of driver’s license offices in Texas?

By Olivia Murray

Every time I’ve ever applied for a new driver’s license while also being involved in the voting process (Arizona, Tennessee, and now Alabama), I’
DiscoverGold DiscoverGold 9 minutes ago
S&P 500 Index (SPX) »» Weekly Summary Analysis
By: Marty Armstrong | August 24, 2024

S&P 500 Cash Index closed today at 563461 and is trading up about 18% for the year from last year's settlement of 476983. Caution is required for this market is starting to suggest it may